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Edited by Hans-Dieter KlenkAbstract Severe acute respiratory syndrome coronavirus
(SARS-CoV) encodes a highly basic nucleocapsid (N) protein
of 422 amino acids. Similar to other coronavirus N proteins,
SARS-CoV N protein is predicted to be phosphorylated and
may contain nuclear localization signals, serine/arginine-rich
motif, RNA binding domain and regions responsible for self-
association and homo-oligomerization. In this study, we demon-
strate that the protein is posttranslationally modiﬁed by covalent
attachment to the small ubiquitin-like modiﬁer. The major
sumoylation site was mapped to the 62lysine residue of the N pro-
tein. Further expression and characterization of wild type N pro-
tein and K62A mutant reveal that sumoylation of the N protein
drastically promotes its homo-oligomerization, and plays certain
roles in the N protein-mediated interference of host cell division.
This is the ﬁrst report showing that a coronavirus N protein
undergoes posttranslational modiﬁcation by sumoylation, and
the functional implication of this modiﬁcation in the formation
of coronavirus ribouncleoprotein complex, virion assembly and
virus–host interactions.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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A novel coronavirus was identiﬁed as the etiological agent of
severe acute respiratory syndrome (SARS) [6,13,17,21]. SARS
coronavirus (SARS-CoV) is an enveloped virus with a single
strand, positive-sense RNA genome of 29.7 kb in length. In
SARS-CoV-infected cells, a 3 0-coterminal nested set of nine
mRNAs species, including the genome-length mRNA
(mRNA1) and eight subgenomic mRNA species (mRNA2–
9), is expressed. The genome-length mRNA1 encodes two
overlapping replicase proteins in the form of polyproteins 1a
and 1a/b, which are processed by virus-encoded proteinases
into at least 16 putative nonstructural proteins (NSP1–
NSP16) [24,29]. The four structural proteins, spike (S), enve-
lope (E), membrane (M) and nucleocapsid (N), are encoded
by subgenomic mRNA 2, 4, 5, and 9, respectively. In addition,
eight putative nonstructural proteins, 3a, 3b, 6, 7a, 7b, 8a, 8b,
9b, are encoded by subgenomic mRNA3, 6, 7, 8, and 9 [24,29].*Corresponding author. Fax: +65 677 911 17.
E-mail address: dxliu@imcb.a-star.edu.sg (D.X. Liu).
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doi:10.1016/j.febslet.2005.03.039All coronaviruses encode an extensively phosphorylated,
highly basic protein. It varies from 377 to 455 amino acids in
length and has high serine content (7–11%), which are poten-
tial targets for phosphorylation. Although the primary se-
quence conservation of the N proteins within the genus is
low, three structural domains can be identiﬁed based on se-
quence comparisons [14]. Of which the middle domain is a po-
tential RNA-binding domain, capable of binding both
coronavirus- and non-coronavirus-derived RNA sequences in
vitro [26]. The functions of domains I and III remain un-
known. However, putative motifs for ribosome binding and
nucleolar localization signals (NuLs) have been identiﬁed in
domain III region [31]. In cells expressing the N protein, it
localizes either to the cytoplasm alone or to the cytoplasm
and nucleolus [9]. This nucleolar localization has been shown
to be a common feature of the coronavirus family [31]. Multi-
ple functions have been postulated for the coronavirus N pro-
tein throughout the virus life cycle. Primarily, the protein can
be associated with the genomic RNA to form a ribonucleopro-
tein complex (RNP) and viral core [5,7,19,20]. It plays an
important role in the replication of the genomic RNA [3],
and in the transcription and translation of subgenomic RNAs
(sgRNA) [1,26,28]. In addition, N protein might inhibit host
cell proliferation or delay cell growth, possibly by disrupting
cytokinesis [4,31]. The protein is generally phosphorylated at
multiple positions and is one of the most abundant structural
proteins [14]. It can also stimulate strong humoral and cellular
immune response, making it a potential vaccine candidate [12].
Similar to other coronaviruses, SARS-CoV N protein is a
highly basic protein (Fig. 1A). Among its 422 amino acids,
there are several basic amino acid-rich regions, that may func-
tion as NuLs and RNA-binding motifs, and a serine/arginine
(S/R) rich motif (Fig. 1A). Sequence comparison and available
evidence showed that the N-terminal one third region (from
amino acid 49 to 178) may contain the RNA binding domain
and the C-terminal half (amino acid 213 to 422) may be
responsible for self-association and homo-oligomerization of
the protein (Fig. 1A) [11,27].
In this study, the SARS-CoV N protein was cloned and ex-
pressed in bacterial and mammalian cells. In Escherichia coli
BL21 cells, the protein was expressed as a single protein spe-
cies. However, multiple protein bands with a wide range of
molecular masses were detected when the N protein was
expressed in mammalian cells, indicating that it may have
undergone posttranslational modiﬁcation in addition to phos-
phorylation and may form homo-oligomers. Biochemical char-
acterization and mutagenesis studies demonstrated that theblished by Elsevier B.V. All rights reserved.
Fig. 1. (A) Schematic representation of the SARS-CoV N protein, showing the SUMO-1 conjugation site (K62), three putative nucleolar localization
signals, the S/R-rich motif, the RNA-binding domain and self-association domain. (B) Analysis of the expression of N protein in bacterial and
mammalian cells. Plasmids pGEX-5X-1 and pGEX-N were transformed into E. coli BL21, and expressed by induction with IPTG. The GST (lane 1)
and GST-N (lane 2) proteins were aﬃnity-puriﬁed and separated on an SDS–10% polyacrylamide gel. The protein was visualized by staining the gel
with Coomassie blue. Total cell lysates prepared from HeLa cells transfected with pKT0-Flag empty plasmid (lane 3) and Flag-tagged N protein (lane
4) were separated by SDS–PAGE and analyzed by Western blotting with anti-Flag antibody. Numbers on the left and right indicate molecular
masses in kilodaltons.
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ment to the small ubiquitin-like modiﬁer (SUMO). The
sumoylation site was mapped to the 62lysine residue of the N
protein. Further expression and characterization of wild type
N protein and K62A mutant revealed that sumoylation drasti-
cally promotes homo-oligomerization of the protein. Sumoyla-
tion of the N protein may also play certain roles in its
interference of host cell division. As self-association and
homo-oligomerization of the N protein are essential for the
formation of viral RNP and nucleocapsid assembly, sumoyla-
tion of this protein may play an important regulatory role in
the SARS-CoV replication cycles.2. Materials and methods
2.1. Cells and cell culture
HeLa cells were cultured in complete Dulbeccos modiﬁed Eagles
medium (Invitrogen) supplemented with 10% newborn calf serum
(Sterile) and 1% penicillin/streptomycin (Invitrogen) and maintained
at 37 C in humidiﬁed 5% CO2.
2.2. Transient expression of viral protein in mammalian cells
Constructs containing plasmid DNA under the control of a T7 pro-
moter were transiently expressed in mammalian cells using a vaccinia
virus-T7 system. Brieﬂy, semiconﬂuent monolayers of HeLa cells were
infected with 10 plaque forming units/cells of recombinant vaccinia
virus (vTF7-3), which expresses the T7 RNA polymerase gene, for
2 h at 37 C prior to transfection. The plasmid DNA was transfected
into vTF7-3-infected cells using Eﬀectene transfection reagent accord-
ing to the manufacturers instructions (Qiagen).2.3. Western blot analysis
Total protein from transfected HeLa cells was lysed with 2· SDS
loading buﬀer and subjected to 10% SDS–PAGE. Protein was trans-
ferred to PVDF membrane (Bio-Rad) by using a semi-dry transfer
cell (Bio-Rad, Trans-blot SD), and blocked overnight at room
temperature with 10% nonfat milk in PBS–T. The membrane was
probed with anti-SARS N, anti-Flag, or anti-Myc antibodies fol-
lowed by anti-mouse or anti-rabbit antibodies conjugated with
horseradish peroxidase (Sigma). Membrane-bound antibodies were
detected with the SuperSignal west pico chemiluminescence substrate
kit (Pierce).2.4. Immunoprecipitation
Transiently transfected HeLa cells in 100-mm dishes were lysed in 1
ml of lysis buﬀer (150 mMNaCl, 1% NP-40, and 50 mM Tris–HCl, pH
8.0) with 0.5% protease inhibitor cocktail (Sigma). The lysates were
centrifuged at 12000 rpm for 20 min at 4 C. The supernatants were
added with anti-SUMO-1 (Zymed), anti-Flag M2 (Stratagene), or
anti-Myc (Biomed Diagnostics) antibodies at 4 C for 2 h. Protein-A
agarose beads (40 ll) (KPL) were added to the lysates and incubated
with shaking for 1 h at 4 C. The beads were collected by centrifuga-
tion and washed for three times with RIPA buﬀer (150 mM NaCl,
1% NP-40, 0.5% sodium deoxycholate, 0.05% SDS, and 50 mM
Tris–HCl, pH 8.0). Proteins binding to the beads were eluted by adding
2· SDS loading buﬀer and analyzed by Western blotting with anti-
Flag antibody.2.5. Expression of GST fusion protein
The SARS-CoV N protein was cloned into pGEX-5X-1 (Amersham
Pharmacia Biotech) and expressed as GST-N fusion protein in E. coli
BL21 cells. Both GST-N and GST alone were puriﬁed by aﬃnity chro-
matography using glutathione–Sepharose 4B (Amersham Pharmacia
Biotech).
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HeLa cells grown on coverslips were transfected with appropriate
constructs expressing the N protein or SUMO-1, and ﬁxed with 4%
paraformaldehyde. The number of cells undergoing cell division was
determined by counting a total of 300 cells that expressing the green
ﬂuorescence protein (GFP). Statistical analysis was performed using
Students t test, and P values less than 0.05 were considered to be sta-
tistically signiﬁcant.
2.7. Indirect immunoﬂuorescence
SARS-CoV N protein was transiently expressed in HeLa cells grown
on 4-well chamber slides (IWAKI). After rinsing with phosphate-buf-
fered saline (PBS), cells were ﬁxed with 4% paraformaldehyde for 15
min at room temperature and permeabilized with 0.2% Triton
X-100, followed by incubation with speciﬁc antibodies diluted in ﬂuo-
rescence dilution buﬀer (PBS with 5% newborn calf serum) at room
temperature for 2 h. Cells were then washed with PBS and incubated
with FITC-conjugated anti-rabbit or anti-mouse secondary antibodies
(Dako) in ﬂuorescence dilution buﬀer at 4 C for 1 h before mounting.
2.8. Construction of plasmids
Plasmid pcDNA3-N, which covers the SARS-CoV N sequence, was
constructed by cloning an EcoRI/NotI digested PCR fragment into
EcoRI/NotI digested pcDNA3.1(+). The PCR fragment was generated
using primers (5 0-CGGAATTCCGATGTCTGATAATG GACCC-30)
and (5 0-AATAAATAGCGGCCGCTGCCTGAGTTG AATC-30).
pFlag-N was created by cloning a PstI/EcoRI digested PCR fragment
into PstI/EcoRI digested pKT0-Flag. The PCR fragment was generated
using primers (5 0-AACTGCAGCATGTCTG ATAATGGACCCC-
3 0) and (5 0-CGGAATTCCGTTATGCCTGAGTTGAATCAGC-3 0).
Plasmid pEGFP-N was generated by cloning an EcoRI- and BamHI-
digested PCR fragment into EcoRI/BamHI digested pEGFP-N1 (Clon-
tech). The two primers used to generate the PCR fragments are
(5 0-CGGAATTCCGATGTCTGATAATGGACCC-30) and (5 0-CG-
GGATCCCGTGCCTGAGTTGA ATCAGC-3 0). Plasmid pGEX-N
was made by cloning a BamHI- and EcoRI-digested PCR fragment into
BamHI/EcoRI digested pGEX-5X-1 (Pharmacia). The two primers
used are (5 0-CGGGATCCCGATGTCTGATAATGGACCC-3 0) and
(5 0-CGGAATTCTGCCTGAGTTGAA TCAGC-3 0). The K62A
mutant was introduced by two rounds of PCR as described in Liu
et al. [16]. All constructs were conﬁrmed by automated nucleotide
sequencing.
SUMO-1 was ampliﬁed from human cDNA derived from HeLa cells
by PCR with primers (5 0-TATCGGATCCCATGTCTGACCA-
GGCAAAACC-3 0) and (5 0-CGGATC CTCGAGCTAAACTGTT-
GAATGACCCCCCGT-3 0). The puriﬁed PCR product was digested
with BamHI and XhoI and cloned into BamHI/XhoI digested
pcDNA3.1(+) to generate pcDNA3-SUMO-1. The construct was con-
ﬁrmed by automated nucleotide sequencing.3. Results
3.1. Expression of SARS-CoV N protein in bacterial and
mammalian cells
To study its biochemical properties and functions in viral
replication, virion assembly and virus–host interaction, we
cloned and expressed the SARS-CoV N protein in bacterial
and mammalian cells. As seen in Fig. 1B, expression of the
protein in E. coli BL21 cells as a GST fusion protein showed
the detection of a single band of approximately 70 kDa, repre-
senting the GST-N fusion protein (Fig. 1B, lane 2). The pro-
tein could be puriﬁed by using the GST resin (Fig. 1B, lane
2). Expression of the N protein tagged with the nine amino
acid Flag tag at its N-terminus in mammalian cells showed
the detection of multiple bands instead of a single protein band
(Fig. 1B, lane 4). Similar to the recently reported detection of
three major isoforms [15], a major protein species of approxi-
mately 48 kDa and two slightly less abundant species, which
migrate more rapidly than the 48-kDa band, were detected(Fig. 1B, lane 4). These three isoforms may represent the
full-length and posttranslationally modiﬁed forms of the N
protein. In addition, three other species with approximately
molecular masses of 175, 85, and 82 kDa, which may represent
oligomerization of the N protein, were sometimes detectable
under reducing conditions (Fig. 1B, lane 4).
3.2. Posttranslational modiﬁcation of SARS-CoV N protein by
sumoylation
The detection of multiple protein species with a wide range
of molecular masses when the N protein was expressed in
mammalian cells indicates that the protein may undergo
other posttranslational modiﬁcation, in addition to the
known phosphorylation. As N protein does not contain
any cysteine residue, the detection of potential oligomers sug-
gests that it may form higher-order structures through other
interactions. Sumoylation is one of the posttranslational
modiﬁcations that aﬀect the migration of the protein. To
detect if the N protein is modiﬁed by sumoylation, cells
transfected with pFlag-N were lysed either with a lysis buﬀer
containing two isopeptidase inhibitors, iodoacetamide (IAA,
10 mM) and N-ethylmaleimide (NEM, 20 mM), or with the
Laemmli protein gel loading buﬀer preheated to 80 C, and
subjected to Western blot analysis with anti-Flag antibody.
As can be seen in Fig. 2A, in addition to the three major iso-
forms of N protein that were detected under all conditions, a
protein species of approximately 65 kDa was detected in cell
lysates prepared with lysis buﬀer containing IAA and NEM
(Fig. 2A, lanes 2, 3, and 5). Occasionally, a band of approx-
imately 55 kDa was also detected in cell lysates prepared
with buﬀer containing IAA and NEM (Fig. 2A, lane 3).
Co-expression of N protein with SUMO-1 led to the detec-
tion of signiﬁcant more 65 kDa species (Fig. 2A, lanes 2
and 3). The 65-kDa band was also detected when cells were
lysed directly with preheated SDS loading buﬀer (Fig. 2A,
lane 6). During the course of this study, we noted that the
65-kDa band could also be eﬃciently detected under nonre-
ducing conditions (Fig. 2A, lanes 5 and 6). Under both
reducing and nonreducing conditions, the three major iso-
forms and the 65-kDa band are migrating at the same posi-
tions. This would allow detection of N proteins in the
subsequent co-immunoprecipitation experiments using SDS–
PAGE under non-reducing conditions. The reason for choos-
ing the non-reducing conditions in these assays is that the
IgG heavy chain would mask the detection of the three
major N isoforms under reducing conditions.
The molecular mass of 65 kDa and its biochemical proper-
ties suggest that this species may represent the sumoylation
of the N protein. To conﬁrm this possibility further, cell lysates
were subjected to immunoprecipitation with either anti-Flag or
anti-SUMO-1 antibody, and then analyzed by Western blot-
ting with anti-Flag antibody. The results showed that anti-Flag
antibody speciﬁcally precipitated the three major isoforms of
N protein from cells transfected with pFlag-N (Fig. 2B, lanes
2 and 3). In addition, the 65-kDa species was also detected
(Fig. 2B, lanes 2 and 3). Analysis of the anti-SUMO-1 precip-
itates by Western blotting with anti-Flag antibody showed that
only the 65-kDa band was detected (Fig. 2B, lanes 5 and 6).
Once again, co-expression of N protein with SUMO-1 greatly
increased the detection of the 65 kDa species (Fig. 2B, lanes 2,
3, 5, and 6). No N protein bands were detected from cells
transfected with SUMO-1 alone (Fig. 2B, lanes 1 and 4). These
Fig. 3. Mapping of the major sumoylation site on SARS-CoV N
protein. Cell lysates from HeLa cells overexpressing wild type (lane 1)
and K62A mutant N protein (lane 2) together with SUMO-1 were
prepared in the presence of IAA and NEM. The polypeptides were
separated by SDS–PAGE under nonreducing conditions and analyzed
by Western blotting with anti-Flag antibody. The three major isoforms
of N protein are indicated by brackets and the major SUMO-1
modiﬁed form of N protein is indicated by asterisks. Numbers on the
left indicate molecular masses in kilodaltons.
Fig. 2. Modiﬁcation of SARS-CoV N protein by SUMO-1. (A) Analysis of sumoylation of N protein by Western blotting. Cell lysates prepared from
HeLa cells overexpressing either the Flag-tagged N protein alone (lanes 1 and 2) or together with SUMO-1 (lanes 3, 4, 5, and 6) were prepared either
in the presence (lanes 2, 3 and 5) or absence (lanes 1 and 4) of the isopeptidase inhibitors IAA and NEM or by direct lysis in preheated SDS loading
buﬀer (lane 6). The polypeptides were separated by SDS–PAGE under either reducing (lanes 1–3) or non-reducing (lanes 4–6) conditions and
analyzed by Western blotting with anti-Flag antibody. The three major isoforms of N protein are indicated by brackets and the major SUMO-1
modiﬁed form of N protein is indicated by asterisks. Numbers on the left indicate molecular masses in kilodaltons. (B) Analysis of sumoylation of N
protein by immunoprecipitation and Western blotting. Total cell lysates were prepared, in the presence of the isopeptidase inhibitors IAA and NEM,
from HeLa cells expressing SUMO-1 (lanes 1 and 4), Flag-N (lanes 2 and 5), and Flag-N + SUMO-1 (lanes 3 and 6), and immunoprecipitated with
either anti-Flag (lanes 1, 2 and 3) or anti-SUMO-1 antibody (lanes 4, 5, and 6). The immunoprecipitated proteins were separated by SDS–PAGE
under nonreducing conditions and analyzed by Western blotting with anti-Flag antibody. The major SUMO-1 modiﬁed forms of N protein are
indicated by asterisks, and the immunoglobulin is indicated by Ig.
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sumoylated N protein.
3.3. Mapping of the sumoylation site on SARS-CoV N protein
The consensus motif for sumoylation has been deﬁned as a
tetrapeptide WKXE (where W is usually a hydrophobic residue
with exceptions, and X is any amino acid) that surrounds the
acceptor lysine in target proteins [23]. Analysis of the N pro-
tein sequence showed that it contains 27 lysine residues. One
lysine residue at amino acid position 62, K62, lies roughly
within the consensus SUMO-1 modiﬁcation sequence (GKEE)
(Fig. 1A). To determine whether this lysine was responsible for
the modiﬁcation of N protein by sumoylation, it was mutated
to an Ala by site-directed mutagenesis. Proteins extracted from
cells transfected with wild-type N and K62A mutant were
immunoblotted with anti-Flag antibody. As shown in Fig. 3,
similar amounts of the three isoforms of N protein were de-
tected from cells transfected with either wild type or mutant
N constructs (Fig. 3, lanes 1 and 2). The 65 kDa sumoylated
band was detected from cells transfected with wild-type N pro-
tein only (Fig. 3, lane 1); no 65 kDa sumoylated form was de-
tected from cells expressing the K62A mutant (Fig. 3, lane 2).
These results demonstrate that the K62 residue is the major
sumoylation site of N protein.
3.4. Promotion of homo-oligomerization of SARS-CoV N
protein by sumoylation
It has been well documented that the ability of viral nucleo-
capsid protein to interact with itself to form homo-oligomers is
fundamental to the process of viral particle assembly. Recent
studies showed that SARS-CoV N protein exhibits intrinsic
properties of self-interaction [8,27]. Multimerization of N pro-
tein was observed both in vitro and in vivo [8,27]. To study the
eﬀects of sumoylation on the homo-oligomerization of N pro-
tein, cells expressing N protein alone or together with SUMO-
1 were analyzed. As shown in Fig. 4, Western blot analysis ofcells expressing wild type N protein showed the detection of
the three major isoforms of N protein and the 65 kDa sumoy-
lated bands (Fig. 4A and B, lanes 1 and 2). In addition, two
bands of approximately 85 and 175 kDa were detected (Fig.
4A and B, lanes 1 and 2). Based on their apparent molecular
masses, they may represent dimers and tetramers, respectively,
of the N protein.
The eﬀects of sumoylation on the formation of these oligo-
mers were then analyzed by expression of wild type and K62A
mutant constructs in cells in the presence of SUMO-1. The
results showed that co-expression of wild type N protein with
SUMO-1 dramatically increased the detection of the 65-kDa
Fig. 4. Analysis of the homo-oligomerization of SARS-CoV N
protein. (A) HeLa cells overexpressing wild type N protein only (lane
1) or together with SUMO-1 (lane 2) were lysed in the absence (lane 1)
or presence of IAA and NEM (lane 2). The polypeptides were
separated by SDS–PAGE under reducing conditions and analyzed by
Western blotting with anti-Flag antibody. The three major isoforms of
N protein are indicated by brackets and the major SUMO-1 modiﬁed
form of N protein is indicated by asterisks. The dimers are also
indicated. Numbers on the left indicate molecular masses in kilodal-
tons. (B) HeLa cells overexpressing wild type N protein only (lanes 1
and 2), wild type + SUMO-1 (lanes 3 and 4) or the K62A mutant N
protein + SUMO-1 (lane 5) were lysed in the presence of IAA and
NEM (lanes 1, 3 and 5) or with preheated SDS loading buﬀer (lanes 2
and 4). The polypeptides were separated by SDS–PAGE under
nonreducing conditions and analyzed by Western blotting with anti-
Flag antibody. The three major isoforms of N protein are indicated by
brackets and the major SUMO-1 modiﬁed form of N protein is
indicated by asterisks. The dimers and tetramers are also indicated.
Numbers on the left indicate molecular masses in kilodaltons.
Fig. 5. Further analysis of the homo-oligomerization of SARS-C-V N
protein. (A) HeLa cells overexpressing the empty pKT0-Flag (lane 1),
wild type N protein (lane 2), or the K62A mutant N protein (lane 3)
were lysed in the presence of IAA and NEM. The lysates were
immunoprecipitated with anti-Flag antibody. The precipitated poly-
peptides were separated by SDS–PAGE under nonreducing conditions
and analyzed by Western blotting with anti-Flag antibody. The three
major isoforms of N protein, the N protein dimer, and the immuno-
globulin are indicated. Numbers on the left indicate molecular masses
in kilodaltons. (B) HeLa cells overexpressing the Flag-tagged wild type
N protein alone (lane 1), the c-Myc-tagged wild type N protein alone
(lane 2), the Flag-tagged wild type and c-Myc-tagged wild type N
protein (lane 3), and the Flag-tagged K62A mutant and c-Myc-tagged
wild type N protein (lane 4) were lysed in the presence of IAA and
NEM. Polypeptides were immunoprecipitated with anti-Myc anti-
body, separated by SDS–PAGE under nonreducing conditions, and
analyzed by Western blotting with anti-Flag antibody. The N protein
dimer and the immunoglobulin are indicated. A band migrating at
approximately 50 kDa, which may represent the antibody heavy chain,
is also indicated. (C) HeLa cells overexpressing the Flag-tagged wild
type N protein alone (lanes 1 and 5), the c-Myc-tagged wild type N
protein alone (lanes 2 and 6), the Flag-tagged wild type and c-Myc-
tagged wild type N protein (lanes 3 and 7), and the Flag-tagged K62A
mutant and c-Myc-tagged wild type N protein (lanes 4 and 8) were
lysed in the presence of IAA and NEM. Polypeptides were separated
by SDS–PAGE under nonreducing conditions, and analyzed by
Western blotting with either anti-Flag antibody (lanes 1–4), or anti-
Myc antibody (lanes 5–8). The three major isoforms of N protein and
the dimer are indicated.
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lanes 3 and 4). Co-expression of the K62A mutant with
SUMO-1, once again, showed no detection of the 65-kDa
sumoylated N protein (Fig. 4B, lane 5). Interestingly, only a
trace amount of the 85- and 175-kDa species was detected
(Fig. 4B, lane 5). These results suggest that abolishment of
the sumoylation of N protein by mutating the K62 sumoyla-
tion site signiﬁcantly decrease homo-oliogomerization of the
protein.
3.5. Further characterization of sumoylation-mediated homo-
oligomerization of SARS-CoV N protein
The eﬀect of sumoylation on homo-oligomerization of N
protein was further characterized by two independent co-
immunoprecipitation experiments. First, cells expressing wild
type and K62A mutant constructs were lysed with buﬀer con-
taining IAA and NEM, immunoprecipitated with anti-Flag
antibody. The immunoprecipitated proteins were separated
in SDS–PAGE and analyzed by Western blotting with anti-
Flag antibody. As shown in Fig. 5A, similar amounts of the
three isoforms of N protein were detected from cells expressing
the wild type and mutant constructs (Fig. 5A, lanes 2 and 3).
However, signiﬁcantly more 85-kDa dimers were detected in
cells expressing the wild type construct than did from cells
expressing the mutant (Fig. 5A, lanes 2 and 3).
Second, the Flag-tagged wild type and mutant N constructs
were co-expressed with a c-Myc-tagged wild type N construct.
Cells were then lysed with buﬀer containing IAA and NEM,immunoprecipitated with anti-Myc antibody. The immuno-
precipitated proteins were separated in SDS–PAGE and ana-
lyzed by Western blotting with anti-Flag antibody. As
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cells co-expressing the Flag-tagged wild type and Myc-tagged
wild type N protein (Fig. 5B, lane 3). Only a trace amount of
the 85-kDa dimers was detected in cells co-expressing the
Flag-tagged K62A mutant and Myc-tagged wild type N pro-
tein (Fig. 5B, lane 4). In addition, a band migrating at approx-
imately 50 kDa position was consistently detected (Fig. 5B). It
might represent the heavy chain of the anti-Myc antibody
used.
To make sure that similar levels of N protein were expressed
in the transfected cells, total cell lysates were analyzed by Wes-
tern blotting with anti-Flag (Fig. 5C, lanes 1–4) and anti-Myc
(Fig. 5C, lanes 5–8) antibodies. The results showed that the
expression levels of ﬂag-tagged wild type and mutant N pro-
tein and the Myc-tagged N protein are approximately the same
(Fig. 5C, lanes 1–4 and 5–8). Interestingly, Western blot anal-
ysis of cells co-expressing Flag- and Myc-tagged wild type N
protein with anti-Flag antibody showed readily detection of
the 85- and 175-kDa oligomers (Fig. 5C, lane 3). Analysis of
the same cell lysates with anti-Myc antibody, however, led to
much less detection of the two forms (Fig. 5C, lane 7). The
two bands were only detectable after prolonged exposure of
the gel (data not shown).
3.6. Eﬀects of sumoylation on the subcellular localization of
SARS-CoV N protein
Subcellular distribution of N protein was ﬁrst studied by
cloning and expressing wild type and K62A mutant N protein
as a fusion protein with the enhanced green ﬂuorescent protein
(EGFP). The plasmid was transfected into HeLa cells and
incubated at 37 C for 36 h. The majority of the SARS-CoV
N-EGFP fusion protein was observed to be distributed
throughout the cytoplasm (Fig. 6B). A certain proportion ofFig. 6. Subcellular localization of SARS-CoV N protein. HeLa cells express
detected directly under the ﬂuorescence microscope at 36 h posttransfection
empty plasmid (D), wild type N protein (E) and K62A mutant (F), was carr
FITC-labeled goat anti-rabbit antibodies. The multinucleated cells are indicthe fusion protein was also observed to be localized to the
nucleolus (Fig. 6B). Similar cytoplasmic localization was
observed when K62A-EGFP fusion protein was expressed in
HeLa cells (Fig. 6C). However, much less, if any, nucleolar
localization was seen in cells expressing this mutant construct
(Fig. 6C).
The wild type and K62A mutant N protein was then cloned
into pcDNA3.1(+) and expressed in HeLa cells. After incuba-
tion at 37 C for 18 h, cells were analyzed by indirect immu-
noﬂuorescence using rabbit anti-SARS-CoV N antiserum,
followed by FITC-labeled goat anti-rabbit antibody. Similar
cytoplasmic localization pattern to the N-EGFP fusion pro-
tein was observed in cells expressing wild type and mutant
N protein (Fig. 6E and F). In some cells, wild type N protein
exhibited typical nucleolar localization (Fig. 6E). Once
again, less obvious nucleolar staining was observed in cells
expressing the K62A mutant (Fig. 6F). These results suggest
that sumoylation of the N protein might aﬀect its nucleolar
localization.
3.7. Nucleolar localization of SARS-CoV N protein
The nucleolar localization pattern of wild type N protein
observed above was conﬁrmed by its colocalization with
ﬁbrillarin in the nucleolus. As shown in Fig. 7, similar cyto-
plasmic and nuclear localization pattern was observed in
cells expressing the Flag-tagged N protein (A). Immunoﬂuo-
rescent staining with anti-ﬁbrillarin antibodies showed typi-
cal nucleolar staining of both transfected and untransfected
cells (Fig. 7B). Interestingly, strong cytoplasmic staining
was also observed in cells expressing the N protein using
the same antibodies (Fig. 7B). The staining patterns co-
aligned well with the patterns observed with anti-Flag
antibodies (Fig. 7C). These results conﬁrm the nucleolaring EGFP (A), N-EGFP (B) and K62A-EGFP fusion protein (C) were
. Indirect immunoﬂuorescent staining of HeLa cells transfected with
ied out at 18 h posttransfection with rabbit anti-SARS N antisera and
ated by arrows.
Fig. 7. Nucleolar localization of SARS-CoV N protein. Indirect immunoﬂuorescent staining of HeLa cells expressing the Flag-tagged N protein was
carried out at 18 h posttransfection with mouse anti-Flag (A) and rabbit anti-ﬁbrillarin (B) antisera. The N protein was then detected by TRITC-
conjugated anti-mouse secondary antibodies and ﬁbrillarin was detected by FITC-labeled anti-rabbit antibodies. (C) represents the merged images.
All images were taken using a Zeiss LSM510 META laser scanning confocal microscope.
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N protein may physically interact with ﬁbrillarin, resulting
in the retention of ﬁbrillarin in the cytoplasm of cells
expressing the N protein.
3.8. Eﬀects of sumoylation on SARS-CoV N protein-mediated
disruption of host cell division
Similar to other coronavirus N protein, overexpression of
SARS-CoV N protein in mammalian cells disrupts the cell
division, as certain proportion of cells expressing the protein
at various time points posttransfection were apparently under-
going cell division (Fig. 6). Furthermore, much less multinucle-
ated cells were observed in cells expressing the K62A mutant
(Fig. 6). To quantitate the multinucleated cells, HeLa cells
transfected with pEGFP, pEGFP-N, pEGFP-N + SUMO-1,
and pEGFP-N(K62A) + SUMO-1 were examined under theFig. 8. Eﬀects of sumoylation of SARS-CoV N protein on its interference of
expressing EGFP, N-EGFP, N-EGFP + SUMO-1, and K62A-EGFP + SUM
green cells under the ﬂuorescence microscope. The percentages and S.D. areﬂuorescence microscope at 24, 36, 48 and 60 h posttransfec-
tion, respectively, and the multinucleated cells were counted
among 300 cells expressing GFP. As shown in Fig. 8, over
25% of HeLa cells expressing pEGFP-N were observed to be
undergoing cell division at all time points. The percentages
of cells undergoing cell division increased to 31–36% among
GFP-positive cells when pEGFP-N were co-expressed with
SUMO-1. However, the percentages of cells undergoing cell
division were markedly reduced to 11–15% in cells over-
expressing the K62A mutant and SUMO-1 (Fig. 8), signiﬁ-
cantly less than (P < 0.05) the multinucleated cells observed
when the wild type construct was expressed. In a control exper-
iment, the percentages of multinucleated cells that overexpress
GFP only were between 2% and 3%. These results indicate that
sumoylation of the N protein may play certain roles in its
interference and disruption of host cell division.host cell division. Percentages of multinucleated cells among HeLa cells
O-1 were calculated by counting the multinucleated cells among 300
results of three repeated experiments.
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In this study, we showed that, in addition to phosphoryla-
tion, the SARS-CoV N protein was modiﬁed by covalent
attachment of SUMO to its 62lysine residue. Evidence
provided demonstrated that sumoylation may promote
homo-oligomerization of the protein. It may also play certain
roles in the N protein-mediated interference of host cell
division.
Sumoylation is a highly regulated process in all eukaryotes,
involving in diverse regulatory events, such as nuclear trans-
port, transcriptional regulation, chromosome segregation and
cell-cycle control [18,23,30]. Conjugation of SUMO to a pro-
tein involves the formation of an isopeptide bond between the
C-terminal glycine of SUMO and the e-amino group of lysine
residue in the target protein. Although SUMO-1 has an esti-
mated molecular mass of approximately 12 kDa, earlier stud-
ies demonstrated that many SUMO-conjugated proteins
usually have a size increase of approximately 20 kDa after
conjugation by one SUMO-1 molecule. SUMO conjugated
proteins are typically unstable and can be rapidly hydrolyzed
by SUMO-1 hydrolase during puriﬁcation. This modiﬁcation
usually alters or regulates the main function of the target
proteins.
Coronavirus N protein is a multi-functional protein [14,31].
Among them, the most prominent function of the protein is
to wrap up the RNA genome to form RNP and assemble
into the nucleocapsid core, due to its RNA-binding activities
and self-association properties. Studies with other coronavi-
rus N protein have mapped the RNA binding domain to
the N-terminal one third region of the protein [14]. A basic
amino acid stretch between amino acids 238 and 293 may
be responsible for the RNA binding activities of the corona-
virus infectious bronchitis virus N protein [34]. Interactions
between N protein and RNA are generally required for
encapsidation of viral genomic RNA. It is possible that
RNA could promote N–N interactions by neutralizing charge
repulsions between the two stretches of basic amino acids. As
the K62 residue is located in the putative RNA-binding
domain of the SARS-CoV N protein, is the reduced homo-
oligomerization of the K62A mutant reported in this study
due to its loss of the RNA binding activity? Although we
do not know if this mutation could aﬀect the RNA-binding
activities of the protein, co-expression of the Flag-tagged
K62A mutant with the Myc-tagged wild type N protein re-
sulted in the detection of remarkably less 85-kDa dimers than
in cells co-expressing the Flag- and Myc-tagged wild type N
protein. As two diﬀerent antibodies were used in the immu-
noprecipitation and Western blot analyses, it virtually rules
out the possibility that the detection of less 85- and 175-
kDa oligomers in Western blot studies involving a single anti-
body is due to a weaker RNA binding activity of the mutant
construct.
Self-association and homo-oligomerization are another
essential property of the coronavirus N protein. Two recent
studies have shown that the S/R-rich motif and the C-terminal
209 amino acids are essential for self-association and multi-
merization of the SARS-CoV N protein [8,27]. The ﬁndings
in this report indicate that the N protein is capable of forming
dimers and higher order multimers. Similar to the equivalent
protein of equine arteritis virus and simian hemorrhagic fever
virus, SARS N protein does not contain any cysteine in its 422amino acid residues. This excludes the possibility that disulﬁde
bonds are the primary force that mediates the initial N–N
interactions. In fact, disulﬁde bonds do not appear to be rele-
vant until the virus enters the secretory pathway (ER and
Golgi) and/or egresses from the cell, both events occurred fol-
lowing the core particle assembly. Data reported in this study
demonstrate that sumoylation of the SARS-CoVNprotein dra-
matically enhances the homo-oligomerization of the protein.
Promotion of oligomerization of protein by sumoylation has
been speculated for a pathogenic protein, Huntingtin [25]. Since
self-association and homo-oligomerization of N protein are
essential for the assembly of nucleocapsid core, it suggests that
sumoylation would play an important role in the SARS-CoV
replication cycles. Systematic testing this possibility would rely
on the availability of an infectious cloning system, as developed
by Yount et al. [33].
The apparent molecular weight of the dimer of the N protein
detected in this report is 85 kDa, suggesting that it does not
contain the SUMO conjugate. The failure to detect the sumoy-
lated dimer in this study is unexpected, considering that
sumoylation was shown to promote dimerization of the N pro-
tein. Two possibilities have been considered. First, sumoyla-
tion is a highly reversible process. The current data showed
that only a small proportion of the N protein was dimerized
compared to the monomers, and a certain proportion of the
sumoylated dimer may be reversed during sample preparation
and detection. The combination of these two factors would
hamper the detection of the sumoylated dimers by the ap-
proaches used. The second possibility is that the sumoylated
N protein may be not directly involved in the formation of di-
mers and other oligomers. Instead, it may target the N protein
to diﬀerent cellular compartments and facilitate the oligomer-
ization of the N protein. Further studies are required to ad-
dress these possibilities.
Site-directed mutagenesis studies mapped the 62lysine residue
as a major site for covalent attachment of SUMO to the pro-
tein, as the 65-kDa sumoylated band cannot be detected when
the mutant construct was expressed in cells. We do not know if
other minor sumoylation sites may exist in the SARS-CoV N
protein. Potential sumoylation at these minor positions would
compensate the eﬀect of K62A mutation, and complicate the
interpretation of the data generating from functional studies,
such as the partial interference of cell division by the K62A mu-
tant N protein. Sumoylation of protein at multiple sites was re-
cently reported for several viral and host proteins. For example,
the Epstein–Barr virus Rta protein was shown to be sumoy-
lated at three alternating sites [2]. As the SARS-CoV N protein
contains a total of 27 lysine residues and no any other lysine res-
idue is located in a consensus sequence context for sumoyla-
tion, it would be diﬃcult to further deﬁne these sites, if any,
by a conventional mutagenesis approach.
SARS-CoV N protein has been found to be translocated to
the nucleolus of host cells, resembling other coronavirus N
proteins, such as IBV [10], MHV and TGEV [31]. This might
be a common strategy for coronaviruses to control both host
and viral RNA translation [10]. However, the functional signif-
icance and the mechanism by which the N protein translocates
to the nucleolus are yet to be determined. Systematic investiga-
tion of NuLS of the SARS-CoV N protein that might target it
to the nucleolus will be carried out based on sequence compar-
ison with other coronaviruses. An alternative possibility that
may account for the nucleolar localization of a viral protein
F.Q. Li et al. / FEBS Letters 579 (2005) 2387–2396 2395is its interaction with certain nucleolar antigens such as ﬁbrill-
arin and nucleolin. This was demonstrated on IBV and MHV
N proteins [4]. Sumoylation of certain host proteins can regu-
late their nucleo-cytoplasmic shuttling [22,32]. The K62A mu-
tant exhibits much less nucleolus localization, indicating that
sumoylation may regulate the subcellular localization of the
SARS-C-V N protein.
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